BRANDY MILES: Open Payments
NPI 1760664817 · PENSACOLA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,414 in 133 payments from 23 companies in 2025. Trend: 2023 $2,247 · 2024 $2,191 · 2025 $3,414
Food & beverage: $2,598Travel & lodging: $816
| Company | Payments | Amount |
|---|---|---|
| Inspire Medical Systems, Inc. | 6 | $913 |
| AstraZeneca Pharmaceuticals LP | 18 | $360 |
| GlaxoSmithKline, LLC. | 21 | $351 |
| Insmed, Inc. | 11 | $230 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 12 | $223 |
| GENZYME CORPORATION | 9 | $217 |
| Viatris Specialty LLC | 9 | $165 |
| Regeneron Healthcare Solutions, Inc. | 7 | $164 |
| Actelion Pharmaceuticals US, Inc. | 6 | $152 |
| Verona Pharma, Inc. | 8 | $149 |
Products named: INSPIRE, DUPIXENT, NUCALA, Arikayce, YUPELRI, TEZSPIRE, Ohtuvayre, FASENRA.
Industry payments across FL — which companies pay providers there.
